NASDAQ: STTK - Shattuck Labs, Inc.

Yield per half year: -72.69%
Sector: Healthcare

Company Analysis Shattuck Labs, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (1.35 $) is less than fair price (4.26 $)

Disadvantages

  • Dividends (0%) are below the sector average (0.5468%).
  • The stock's return over the last year (-83.26%) is lower than the sector average (-19.51%).
  • Current debt level 2.63% has increased over 5 years from 0%.
  • The company's current efficiency (ROE=-60.33%) is lower than the sector average (ROE=9.61%)

Similar companies

Alexion

ABIOMED

Amgen

Gilead Sciences

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Shattuck Labs, Inc. Healthcare Index
7 days -10% -12.7% -1.3%
90 days -70.8% -27.8% 9.3%
1 year -83.3% -19.5% 31.8%

STTK vs Sector: Shattuck Labs, Inc. has significantly underperformed the "Healthcare" sector by -63.75% over the past year.

STTK vs Market: Shattuck Labs, Inc. has significantly underperformed the market by -115.1% over the past year.

Slightly volatile price: STTK is more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of about +/- 5-15% per week.

Long period: STTK with weekly volatility of -1.6% over the past year.

3. Summary of the report

3.1. General

P/E: 0
P/S: 169.81

3.2. Revenue

EPS -2.05
ROE -60.33%
ROA -54.71%
ROIC -20.71%
Ebitda margin -5305.67%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (1.35 $) is lower than the fair price (4.26 $).

Price significantly below the fair price: The current price (1.35 $) is 215.6% lower than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (48.77).

P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (48.89).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.94) is lower than that of the sector as a whole (4.82).

P/BV vs Market: The company's P/BV (1.94) is lower than that of the market as a whole (3.36).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (169.81) is higher than that of the sector as a whole (33.76).

P/S vs Market: The company's P/S indicator (169.81) is higher than that of the market as a whole (10.23).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (-1.82) is higher than that of the sector as a whole (-22.15).

EV/Ebitda vs Market: The company's EV/Ebitda (-1.82) is lower than that of the market as a whole (28.27).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 56.24% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (56.24%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.16%).

5.4. ROE

ROE vs Sector: The company's ROE (-60.33%) is lower than that of the sector as a whole (9.61%).

ROE vs Market: The company's ROE (-60.33%) is lower than that of the market as a whole (10.79%).

5.5. ROA

ROA vs Sector: The company's ROA (-54.71%) is lower than that of the sector as a whole (0.3443%).

ROA vs Market: The company's ROA (-54.71%) is lower than that of the market as a whole (6.51%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (-20.71%) is lower than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (-20.71%) is lower than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (2.63%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0% to 2.63%.

Excess of debt: The debt is not covered by net income, percentage -4.81%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.5468%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
04.12.2024 Redmile Group, LLC
Director
Sale 1.25 166 714 133 371
04.12.2024 Redmile Group, LLC
Director
Purchase 1.25 166 714 133 371
26.06.2024 Schreiber Taylor
Chief Executive Officer
Purchase 3.47 49 968 14 400
28.01.2022 Schreiber Taylor
Chief Executive Officer
Purchase 4.67 18 334 3 926
19.01.2022 Brous Tyler
Director
Purchase 6.87 20 610 3 000

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Shattuck Labs, Inc.

9.3. Comments